Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Djeneba Audrey Djibo
Aetna, Inc.
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
72
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Background Rates of Adverse Events of Special Interest for COVID-19 Vaccine Safety Monitoring in the United States, 2019–2020
Number of pages: 30
Posted: 08 Sep 2022
Keran Moll
,
Bradley Lufkin
,
Kathryn R. Fingar
,
Cindy Ke Zhou
,
Ellen Tworkoski
,
Chianti Shi
,
Shayan Hobbi
,
Mao Hu
,
Minya Sheng
,
Jillian McCarty
,
Shanlai Shangguan
,
Timothy Burrell
,
Yoganand Chillarige
,
Jeff Beers
,
Patrick Saunders-Hastings
,
Kathryn Edwards
,
Stella Muthuri
,
Steven Black
,
Jeffrey A. Kelman
,
Christin Reich
,
Kandace Amend
, Djeneba Audrey Djibo,
Daniel C. Beachler
,
Rachel P. Ogilvie
,
Alex Secora
,
Cheryl N. McMahill-Walraven
,
Seeger John
,
Patricia Lloyd
,
Deborah Thompson
,
Rositsa Dimova
,
Thomas MaCurdy
,
Joyce Obidi
,
Steven A. Anderson
,
Richard A. Forshee
,
Hui-Lee Wong
and
Azadeh Shoaibi
IBM Consulting, Acumen, LLC, IBM Consulting, U.S. Food and Drug Administration, Acumen, LLC, Acumen, LLC, IBM Consulting, Acumen, LLC, IBM Consulting, IBM Consulting, Acumen, LLC, IBM Consulting, Acumen, LLC, IBM Consulting, Gevity Inc, IBM Consulting, IBM Consulting, IBM Consulting, Centers for Medicare and Medicaid Services, IQVIA - Real World Solutions, Epidemiology, Optum, Aetna, Inc., Anthem Inc. - HealthCore, Epidemiology, Optum, IQVIA, Aetna, Inc., Epidemiology, Optum, U.S. Food and Drug Administration, Acumen, LLC, Acumen, LLC, Acumen, LLC, U.S. Food and Drug Administration, U.S. Food and Drug Administration, U.S. Food and Drug Administration, U.S. Food and Drug Administration and U.S. Food and Drug Administration
Downloads
72
(860,052)
View PDF
Download
Abstract:
background rates, vaccine safety surveillance, COVID-19, adverse events
Feedback